PlainHospital

BAYER

Manufacturer adverse-event records for BAYER come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2000–2025 · mid-book · typical Death-code · injury-heavy

Injury-mix signature

BAYER leans injury-heavy in event_type mix

Injury-coded event_type share is 98.2% (injury-heavy tercile) beside 0.36% Death-coded (typical). Volume band: mid.

What the Injury-mix reading shows for BAYER

The standout signal for BAYER is Injury-mix: 98.2% Injury-coded (injury-heavy) beside 0.36% Death-coded, on a mid-book footprint.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for BAYER. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 17 device types, led in this extract by Injury at 7,679 (98.2% of event_type total). Peak single-year volume reaches 3,722 reports across 18 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

7,816
Total Reports
28
Event-type Death
7,679
Injury Reports
17
Device Types

Event Types

Injury 7,679 (98.2%)
48 (0.6%)
Malfunction 42 (0.5%)
Death 28 (0.4%)
Other 19 (0.2%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Hospitalization 3,257 (25.4%)
Other 2,673 (20.9%)
O 1,757 (13.7%)
R 1,397 (10.9%)
S 1,359 (10.6%)
835 (6.5%)
Required Intervention 488 (3.8%)
L 429 (3.3%)
Disability 349 (2.7%)
Life Threatening 158 (1.2%)
H 49 (0.4%)
Congenital Anomaly 34 (0.3%)
Death 23 (0.2%)
D 4 (0.0%)

Devices (17)

Device Reports
Transcervical Contraceptive Tubal Occlusion Device 7,761
System, Test, Blood Glucose, Over The Counter 22
Hexokinase, Glucose 5
Injector And Syringe, Angiographic 5
Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature 5
Laparoscopic Contraceptive Tubal Occlusion Device 3
Device, Intrauterine, Contraceptive And Introducer 2
Device, Thermal Ablation, Endometrial 2
Glucose Dehydrogenase, Glucose 2
Tubing, Fluid Delivery 2
Glucose Oxidase, Glucose 1
Heater, Perineal, Radiant, Non-Contact 1
Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms) 1
Nitroprusside, Ketones (Urinary, Non-Quant.) 1
Pad, Menstrual, Unscented 1
Pessary, Vaginal 1
Syringe, Piston 1

Yearly Trend

00
2000: 2
01
2001: 2
03
2003: 1
05
2005: 1
06
2006: 2
08
2008: 2
10
2010: 3
11
2011: 1
13
2013: 156
14
2014: 1,134
15
2015: 3,722
16
2016: 2,003
17
2017: 605
18
2018: 176
20
2020: 1
21
2021: 1
23
2023: 3
25
2025: 1

Read our methodology - how this data is sourced, computed, and verified.